MOTUS

Pharmaceuticals and medicines for the treatment of metabolic diseases and disorders, including diabetes, metabolic syndrome and cachexia, and gastrointestinal diseases and disorders, including gastroparesis, post-operative ileus, chronic constipation, and inflammatory bowel disease

Research and product development services in the fields of metabolic diseases and disorders, including diabetes, metabolic syndrome and cachexia, and gastrointestinal diseases and disorders, including gastroparesis, post-operative ileus, chronic constipation, and inflammatory bowel disease